Breakthrough Method Detects Inflammation via Blood Tests

Inflammation plays a role in nearly every disease, yet pinpointing inflammation in specific organs using blood tests has been a challenge. A group of researchers at Case Western Reserve University have developed a groundbreaking method to detect inflammation in the body through antibodies. This advancement could lead to the development of blood tests for disease-specific biomarkers, improving diagnosis and detection for conditions such as heart disease, Alzheimer’s, and various cancers. Furthermore, it holds significant promise for drug discovery.

This research opens up an amazing number of pathways for future studies. It will lead directly to better understanding inflammation and detecting diseases, as well as to discovering new drugs.

Greg Tochtrop, Professor of Chemistry at Case Western Reserve

Understanding Inflammation

During inflammation, immune cells generate reactive oxygen species (ROS)—highly reactive oxygen-containing chemicals that can cause damage to DNA, proteins, and lipids. While ROS help combat bacteria and pathogens, excessive amounts can lead to cellular and tissue damage. Tochtrop and his team found that ROS interact with linoleic acid, a fatty acid present in cell membranes, forming epoxyketooctadecanoic acids (EKODEs). These compounds can bind to nucleic acid cysteine, creating a stable bond and accumulating in tissues experiencing oxidative stress.

The Discovery

Tochtrop used mouse models to develop antibodies to detect EKODEs in tissues from different organs, both in mice and humans. This discovery allowed the researchers to identify unique compounds and concentrations in various tissues, suggesting the potential for detecting numerous diseases using blood tests. These tests could be analogous to the A1C test for diabetes, offering insight into long-term oxidative stress in specific organs.

Identifying Biomarkers

The researchers synthesized EKODE model compounds and studied their reactions with various amino acids, finding that cysteine is the only amino acid to which EKODE could bind for a significant period. This finding underscores the importance of looking at fundamental chemistry to guide further clinical tests and drug discovery.

“We looked at the inherent chemistry of the system, predicted what would form and then searched for them,” Tochtrop explained. “There are very important translational implications, but this is an example of how looking at things from first principles can really inform the next steps to developing clinical tests.”

Implications for Drug Discovery

The research could also contribute to drug discovery. Identifying reactive cysteines is currently a crucial aspect of drug development. By uncovering these reactive cysteines, researchers could target them for new drug therapies.

“Identifying reactive cysteines is central to drug discovery right now,” Tochtrop emphasized. “This could help uncover many reactive cysteines that could be targeted for drug discovery, which is a valuable offshoot of our research.”

Future Directions

The potential applications of this research are vast. By developing sensitive methods to detect inflammation in specific organs, this breakthrough could revolutionize diagnostics, allowing for earlier and more accurate detection of various diseases. The method also promises to accelerate the search for new therapeutic targets, ultimately benefiting patients and improving public health.